What is it about?
Econometric analysis of the impact of patents, regulatory filings and R&D expenditure on pharma exports
Featured Image
Why is it important?
It suggests the strength of causality between patent and exports, regulatory filings and exports and also among R&D expenditure and exports
Perspectives
Paper suggested an interesting dimension about Indian pharmaceutical industry wherein patents are not driving exports and that the R&D expenditure is mainly driven towards generics development leading to regulatory filings and eventually exports.
Dr Feroz Khan Suri
National Institute of Technology Bhopal
Read the Original
This page is a summary of: Impact of R and D Intensity, Patents and Regulatory Filings on Export Intensity of Indian Pharmaceutical Industry, Indian Journal of Pharmaceutical Education and Research, September 2019, EManuscript Services,
DOI: 10.5530/ijper.53.4.125.
You can read the full text:
Contributors
The following have contributed to this page
